Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

News provided by

Apr 05, 2012, 05:28 ET

NEW YORK, April 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

http://www.reportlinker.com/p0829625/Clinical-Chemistry-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary Brazil Russia India China South Africa

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the six market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.

- 2010 company shares and distribution shares data for the overall Clinical Chemistry market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Clinical Chemistry market in BRICS.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Abbott Laboratories, Shanghai Kehua Bio-engineering Co., Ltd., Mindray Medical International Limited, Transasia Bio-Medicals Ltd. and Sysmex Corporation.

Reasons to buy

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Clinical Chemistry competitive landscape in BRICS.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 102 Introduction 132.1 What is This Report About? 133 Clinical Chemistry in BRICS 143.1 Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, 2003-2017 143.2 Clinical Chemistry, BRICS, Company share (2009-2010) 204 Clinical Chemistry In Brazil 224.1 Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 224.2 Metabolite Chemistry Reagents In Brazil 284.2.1 Metabolite Chemistry Reagents, Brazil, Overall Revenue (2003-2017) 284.3 Clinical Chemisty Analyzers In Brazil 304.3.1 Clinical Chemisty Analyzers, Brazil, Overall Revenue (2003-2017) 304.4 Enzyme Chemistry Reagents In Brazil 334.4.1 Enzyme Chemistry Reagents, Brazil, Overall Revenue (2003-2017) 334.5 Clinical Chemistry Rapid Tests & POC In Brazil 354.5.1 Clinical Chemistry Rapid Tests & POC, Brazil, Overall Revenue (2003-2017) 354.6 Electrolyte Chemistry Reagents In Brazil 374.6.1 Electrolyte Chemistry Reagents, Brazil, Overall Revenue (2003-2017) 374.7 Urine Analysis In Brazil 394.7.1 Urine Analysis, Brazil, Overall Revenue (2003-2017) 394.8 Clinical Chemistry, Brazil, Distribution Share (2009-2010) 424.9 Clinical Chemistry, Brazil, Company Share (2009-2010) 435 Clinical Chemistry In Russian Federation 455.1 Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 455.2 Clinical Chemisty Analyzers In Russian Federation 515.2.1 Clinical Chemisty Analyzers, Russian Federation, Overall Revenue (2003-2017) 515.3 Urine Analysis In Russian Federation 555.3.1 Urine Analysis, Russian Federation, Overall Revenue (2003-2017) 555.4 Metabolite Chemistry Reagents In Russian Federation 585.4.1 Metabolite Chemistry Reagents, Russian Federation, Overall Revenue (2003-2017) 585.5 Clinical Chemistry Rapid Tests & POC In Russian Federation 605.5.1 Clinical Chemistry Rapid Tests & POC, Russian Federation, Overall Revenue (2003-2017) 605.6 Enzyme Chemistry Reagents In Russian Federation 625.6.1 Enzyme Chemistry Reagents, Russian Federation, Overall Revenue (2003-2017) 625.7 Electrolyte Chemistry Reagents In Russian Federation 645.7.1 Electrolyte Chemistry Reagents, Russian Federation, Overall Revenue (2003-2017) 645.8 Clinical Chemistry, Russian Federation, Distribution Share (2009-2010) 665.9 Clinical Chemistry, Russian Federation, Company Share (2009-2010) 676 Clinical Chemistry In India 696.1 Clinical Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 696.2 Clinical Chemistry Rapid Tests & POC In India 756.2.1 Clinical Chemistry Rapid Tests & POC, India, Overall Revenue (2003-2017) 756.3 Clinical Chemisty Analyzers In India 776.3.1 Clinical Chemisty Analyzers, India, Overall Revenue (2003-2017) 776.4 Urine Analysis In India 806.4.1 Urine Analysis, India, Overall Revenue (2003-2017) 806.5 Metabolite Chemistry Reagents In India 836.5.1 Metabolite Chemistry Reagents, India, Overall Revenue (2003-2017) 836.6 Enzyme Chemistry Reagents In India 856.6.1 Enzyme Chemistry Reagents, India, Overall Revenue (2003-2017) 856.7 Electrolyte Chemistry Reagents In India 876.7.1 Electrolyte Chemistry Reagents, India, Overall Revenue (2003-2017) 876.8 Clinical Chemistry, India, Distribution Share (2009-2010) 896.9 Clinical Chemistry, India, Company Share (2009-2010) 907 Clinical Chemistry In China 927.1 Clinical Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 927.2 Clinical Chemistry Rapid Tests & POC In China 987.2.1 Clinical Chemistry Rapid Tests & POC, China, Overall Revenue (2003-2017) 987.3 Urine Analysis In China 1007.3.1 Urine Analysis, China, Overall Revenue (2003-2017) 1007.4 Clinical Chemisty Analyzers In China 1037.4.1 Clinical Chemisty Analyzers, China, Overall Revenue (2003-2017) 1037.5 Metabolite Chemistry Reagents In China 1077.5.1 Metabolite Chemistry Reagents, China, Overall Revenue (2003-2017) 1077.6 Enzyme Chemistry Reagents In China 1097.6.1 Enzyme Chemistry Reagents, China, Overall Revenue (2003-2017) 1097.7 Electrolyte Chemistry Reagents In China 1117.7.1 Electrolyte Chemistry Reagents, China, Overall Revenue (2003-2017) 1117.8 Clinical Chemistry, China, Distribution Share (2009-2010) 1137.9 Clinical Chemistry, China, Company Share (2009-2010) 1148 Clinical Chemistry In South Africa 1168.1 Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 1168.2 Clinical Chemistry Rapid Tests & POC In South Africa 1228.2.1 Clinical Chemistry Rapid Tests & POC, South Africa, Overall Revenue (2003-2017) 1228.3 Clinical Chemisty Analyzers In South Africa 1248.3.1 Clinical Chemisty Analyzers, South Africa, Overall Revenue (2003-2017) 1248.4 Urine Analysis In South Africa 1288.4.1 Urine Analysis, South Africa, Overall Revenue (2003-2017) 1288.5 Metabolite Chemistry Reagents In South Africa 1328.5.1 Metabolite Chemistry Reagents, South Africa, Overall Revenue (2003-2017) 1328.6 Enzyme Chemistry Reagents In South Africa 1348.6.1 Enzyme Chemistry Reagents, South Africa, Overall Revenue (2003-2017) 1348.7 Electrolyte Chemistry Reagents In South Africa 1368.7.1 Electrolyte Chemistry Reagents, South Africa, Overall Revenue (2003-2017) 1368.8 Clinical Chemistry, South Africa, Distribution Share (2009-2010) 1388.9 Clinical Chemistry, South Africa, Company Share (2009-2010) 1399 Overview of Key Companies in BRICS Clinical Chemistry Market 1419.1 F. Hoffmann-La Roche Ltd. 1419.1.1 Company Overview 1419.1.2 Share in the BRICS Clinical Chemistry Market 1429.2 Siemens Healthcare 1439.2.1 Company Overview 1439.2.2 Share in the BRICS Clinical Chemistry Market 1439.3 Ortho-Clinical Diagnostics Inc. 1459.3.1 Company Overview 1459.3.2 Share in the BRICS Clinical Chemistry Market 1459.4 Beckman Coulter, Inc. 1479.4.1 Company Overview 1479.4.2 Share in the BRICS Clinical Chemistry Market 1479.5 Abbott Laboratories 1499.5.1 Company Overview 1499.5.2 Share in the BRICS Clinical Chemistry Market 1499.6 Shanghai Kehua Bio-engineering Co., Ltd. 1519.6.1 Company Overview 1519.6.2 Share in the BRICS Clinical Chemistry Market 1519.7 Mindray Medical International Limited 1529.7.1 Company Overview 1529.7.2 Share in the BRICS Clinical Chemistry Market 1529.8 Transasia Bio-Medicals Ltd. 1549.8.1 Company Overview 1549.8.2 Share in the BRICS Clinical Chemistry Market 1549.9 Sysmex Corporation 1559.9.1 Company Overview 1559.9.2 Share in the BRICS Clinical Chemistry Market 1569.10 Trivitron Healthcare Pvt Ltd. 1579.10.1 Company Overview 1579.11 Span Diagnostics Ltd. 1579.11.1 Company Overview 1579.12 OLYMPUS CORPORATION 1579.12.1 Company Overview 15710 Appendix 15810.1 Definitions of Markets Covered in the Report 15910.1.1 Clinical Chemistry 15910.2 Research Methodology 16010.3 Secondary Research 16010.4 Primary Research 16110.5 Models 16110.6 Forecasts 16210.7 Expert Panels 16210.8 GlobalData Consulting 16210.9 Currency Conversion 16310.10 Contact Us 16310.11 Disclaimer 163

List of Tables

Table 1: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, 2003-2017 15Table 2: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, Historic, 2003-2010 17Table 3: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 19Table 4: Clinical Chemistry, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 21Table 5: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23Table 6: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25Table 7: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27Table 8: Metabolite Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 28Table 9: Metabolite Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 29Table 10: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 31Table 11: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 32Table 12: Enzyme Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 33Table 13: Enzyme Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 34Table 14: Clinical Chemistry Rapid Tests & POC, Brazil, Revenue ($m), Historic, 2003-2010 35Table 15: Clinical Chemistry Rapid Tests & POC, Brazil, Revenue ($m), Forecast, 2010-2017 36Table 16: Electrolyte Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 37Table 17: Electrolyte Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 38Table 18: Urine Analysis, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 40Table 19: Urine Analysis, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 41Table 20: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 42Table 21: Clinical Chemistry, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 44Table 22: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 46Table 23: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 48Table 24: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 50Table 25: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 52Table 26: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 54Table 27: Urine Analysis, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 56Table 28: Urine Analysis, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 57Table 29: Metabolite Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 58Table 30: Metabolite Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 59Table 31: Clinical Chemistry Rapid Tests & POC, Russian Federation, Revenue ($m), Historic, 2003-2010 60Table 32: Clinical Chemistry Rapid Tests & POC, Russian Federation, Revenue ($m), Forecast, 2010-2017 61Table 33: Enzyme Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 62Table 34: Enzyme Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 63Table 35: Electrolyte Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 64Table 36: Electrolyte Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 65Table 37: Clinical Chemistry, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 66Table 38: Clinical Chemistry, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 68Table 39: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 70Table 40: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 72Table 41: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 74Table 42: Clinical Chemistry Rapid Tests & POC, India, Revenue ($m), Historic, 2003-2010 75Table 43: Clinical Chemistry Rapid Tests & POC, India, Revenue ($m), Forecast, 2010-2017 76Table 44: Clinical Chemisty Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 78Table 45: Clinical Chemisty Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 79Table 46: Urine Analysis, India, Revenue ($m) by Segment, Historic, 2003-2010 81Table 47: Urine Analysis, India, Revenue ($m) by Segment, Forecast, 2010-2017 82Table 48: Metabolite Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 83Table 49: Metabolite Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 84Table 50: Enzyme Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 85Table 51: Enzyme Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 86Table 52: Electrolyte Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 87Table 53: Electrolyte Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 88Table 54: Clinical Chemistry, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 89Table 55: Clinical Chemistry, India, Company share by Revenue ($m), USD Actual, 2009-2010 91Table 56: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 93Table 57: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 95Table 58: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 97Table 59: Clinical Chemistry Rapid Tests & POC, China, Revenue ($m), Historic, 2003-2010 98Table 60: Clinical Chemistry Rapid Tests & POC, China, Revenue ($m), Forecast, 2010-2017 99Table 61: Urine Analysis, China, Revenue ($m) by Segment, Historic, 2003-2010 101Table 62: Urine Analysis, China, Revenue ($m) by Segment, Forecast, 2010-2017 102Table 63: Clinical Chemisty Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 104Table 64: Clinical Chemisty Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 106Table 65: Metabolite Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 107Table 66: Metabolite Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 108Table 67: Enzyme Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 109Table 68: Enzyme Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 110Table 69: Electrolyte Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 111Table 70: Electrolyte Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 112Table 71: Clinical Chemistry, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 113Table 72: Clinical Chemistry, China, Company share by Revenue ($m), USD Actual, 2009-2010 115Table 73: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 117Table 74: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 119Table 75: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 121Table 76: Clinical Chemistry Rapid Tests & POC, South Africa, Revenue ($m), Historic, 2003-2010 122Table 77: Clinical Chemistry Rapid Tests & POC, South Africa, Revenue ($m), Forecast, 2010-2017 123Table 78: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 125Table 79: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 127Table 80: Urine Analysis, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 129Table 81: Urine Analysis, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 131Table 82: Metabolite Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 132Table 83: Metabolite Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 133Table 84: Enzyme Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 134Table 85: Enzyme Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 135Table 86: Electrolyte Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 136Table 87: Electrolyte Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 137Table 88: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 138Table 89: Clinical Chemistry, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010 140Table 90: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Clinical Chemistry Market, 2010 142Table 91: Siemens Healthcare, Revenue ($m), BRICS Clinical Chemistry Market, 2010 144Table 92: Ortho-Clinical Diagnostics Inc., Revenue ($m), BRICS Clinical Chemistry Market, 2010 146Table 93: Beckman Coulter, Inc., Revenue ($m), BRICS Clinical Chemistry Market, 2010 148Table 94: Abbott Laboratories, Revenue ($m), BRICS Clinical Chemistry Market, 2010 150Table 95: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), BRICS Clinical Chemistry Market, 2010 151Table 96: Mindray Medical International Limited, Revenue ($m), BRICS Clinical Chemistry Market, 2010 153Table 97: Transasia Bio-Medicals Ltd., Revenue ($m), BRICS Clinical Chemistry Market, 2010 154Table 98: Sysmex Corporation, Revenue ($m), BRICS Clinical Chemistry Market, 2010 156Table 99: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 163

List of Figures

Figure 1: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, 2003-2017 14Figure 2: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, Historic, 2003-2010 16Figure 3: Clinical Chemistry, BRICS, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 18Figure 4: Clinical Chemistry, BRICS, Company share (%), 2010 20Figure 5: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 22Figure 6: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24Figure 7: Clinical Chemistry, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26Figure 8: Metabolite Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 28Figure 9: Metabolite Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 29Figure 10: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 30Figure 11: Clinical Chemisty Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 32Figure 12: Enzyme Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 33Figure 13: Enzyme Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 34Figure 14: Clinical Chemistry Rapid Tests & POC, Brazil, Revenue ($m), Historic, 2003-2010 35Figure 15: Clinical Chemistry Rapid Tests & POC, Brazil, Revenue ($m), Forecast, 2010-2017 36Figure 16: Electrolyte Chemistry Reagents, Brazil, Revenue ($m), Historic, 2003-2010 37Figure 17: Electrolyte Chemistry Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 38Figure 18: Urine Analysis, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 39Figure 19: Urine Analysis, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 41Figure 20: Clinical Chemistry, Brazil, Company share (%), 2010 43Figure 21: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 45Figure 22: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 47Figure 23: Clinical Chemistry, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 49Figure 24: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 51Figure 25: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 53Figure 26: Urine Analysis, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 55Figure 27: Urine Analysis, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 57Figure 28: Metabolite Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 58Figure 29: Metabolite Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 59Figure 30: Clinical Chemistry Rapid Tests & POC, Russian Federation, Revenue ($m), Historic, 2003-2010 60Figure 31: Clinical Chemistry Rapid Tests & POC, Russian Federation, Revenue ($m), Forecast, 2010-2017 61Figure 32: Enzyme Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 62Figure 33: Enzyme Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 63Figure 34: Electrolyte Chemistry Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 64Figure 35: Electrolyte Chemistry Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 65Figure 36: Clinical Chemistry, Russian Federation, Company share (%), 2010 67Figure 37: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, 2003-2017 69Figure 38: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 71Figure 39: Clinical Chemistry, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 73Figure 40: Clinical Chemistry Rapid Tests & POC, India, Revenue ($m), Historic, 2003-2010 75Figure 41: Clinical Chemistry Rapid Tests & POC, India, Revenue ($m), Forecast, 2010-2017 76Figure 42: Clinical Chemisty Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 77Figure 43: Clinical Chemisty Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 79Figure 44: Urine Analysis, India, Revenue ($m) by Segment, Historic, 2003-2010 80Figure 45: Urine Analysis, India, Revenue ($m) by Segment, Forecast, 2010-2017 82Figure 46: Metabolite Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 83Figure 47: Metabolite Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 84Figure 48: Enzyme Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 85Figure 49: Enzyme Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 86Figure 50: Electrolyte Chemistry Reagents, India, Revenue ($m), Historic, 2003-2010 87Figure 51: Electrolyte Chemistry Reagents, India, Revenue ($m), Forecast, 2010-2017 88Figure 52: Clinical Chemistry, India, Company share (%), 2010 90Figure 53: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, 2003-2017 92Figure 54: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 94Figure 55: Clinical Chemistry, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 96Figure 56: Clinical Chemistry Rapid Tests & POC, China, Revenue ($m), Historic, 2003-2010 98Figure 57: Clinical Chemistry Rapid Tests & POC, China, Revenue ($m), Forecast, 2010-2017 99Figure 58: Urine Analysis, China, Revenue ($m) by Segment, Historic, 2003-2010 100Figure 59: Urine Analysis, China, Revenue ($m) by Segment, Forecast, 2010-2017 102Figure 60: Clinical Chemisty Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 103Figure 61: Clinical Chemisty Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 105Figure 62: Metabolite Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 107Figure 63: Metabolite Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 108Figure 64: Enzyme Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 109Figure 65: Enzyme Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 110Figure 66: Electrolyte Chemistry Reagents, China, Revenue ($m), Historic, 2003-2010 111Figure 67: Electrolyte Chemistry Reagents, China, Revenue ($m), Forecast, 2010-2017 112Figure 68: Clinical Chemistry, China, Company share (%), 2010 114Figure 69: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 116Figure 70: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 118Figure 71: Clinical Chemistry, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 120Figure 72: Clinical Chemistry Rapid Tests & POC, South Africa, Revenue ($m), Historic, 2003-2010 122Figure 73: Clinical Chemistry Rapid Tests & POC, South Africa, Revenue ($m), Forecast, 2010-2017 123Figure 74: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 124Figure 75: Clinical Chemisty Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 126Figure 76: Urine Analysis, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 128Figure 77: Urine Analysis, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 130Figure 78: Metabolite Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 132Figure 79: Metabolite Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 133Figure 80: Enzyme Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 134Figure 81: Enzyme Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 135Figure 82: Electrolyte Chemistry Reagents, South Africa, Revenue ($m), Historic, 2003-2010 136Figure 83: Electrolyte Chemistry Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 137Figure 84: Clinical Chemistry, South Africa, Company share (%), 2010 139Figure 85: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Clinical Chemistry Market, 2010 142Figure 86: Siemens Healthcare, Company Share (%), BRICS Clinical Chemistry Market, 2010 143Figure 87: Ortho-Clinical Diagnostics Inc., Company Share (%), BRICS Clinical Chemistry Market, 2010 145Figure 88: Beckman Coulter, Inc., Company Share (%), BRICS Clinical Chemistry Market, 2010 147Figure 89: Abbott Laboratories, Company Share (%), BRICS Clinical Chemistry Market, 2010 149Figure 90: Mindray Medical International Limited, Company Share (%), BRICS Clinical Chemistry Market, 2010 152Figure 91: Sysmex Corporation, Company Share (%), BRICS Clinical Chemistry Market, 2010 156